A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines

Guardado en:

Detalles Bibliográficos
Publicado en:	PLoS One vol. 19, no. 1 (Jan 2024), p. e0294025
Autor principal:	Gehring, Stephan
Otros Autores:	Kowalzik, Frank, Okasha, Omar, Engelmann, Tobias, Schreiner, Daniel, Jensen, Christian, Mähringer-Kunz, Aline, Hartig-Merkel, Wendy, Thao Mai Phuong Tran, Oostvogels, Cornelia, Verstraeten, Thomas
Publicado:	Public Library of Science
Materias:	Food & Drug Administration > FDA United States > US Germany Enrollments Infections Population COVID-19 vaccines Anosmia Antibodies Severe acute respiratory syndrome coronavirus 2 Signs and symptoms Medical personnel Risk factors Seroepidemiology Polymerase chain reaction Serology Viral diseases Immunization Chronic obstructive pulmonary disease Drug dosages Health care Coronaviruses Asthma Cough Pandemics Hypertension Cohort analysis Vaccines Viral infections Real time Seroconversion Disease transmission Local population COVID-19 Observational studies Social
Acceso en línea:	Citation/Abstract Full Text Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!